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Summary
Selective genetic manipulation of neuronal function in
vivo requires techniques for targeting gene expres-
sion to specific cells. Existing systems accomplish
this using the promoters of endogenous genes to
drive expression of transgenes directly in cells of
interest or, in ‘‘binary’’ systems, to drive expression
of a transcription factor or recombinase that subse-
quently activates the expression of other transgenes.
All such techniques are constrained by the limited
specificity of the available promoters. We introduce
here a combinatorial system inwhich the DNA-binding
(DBD) and transcription-activation (AD) domains of a
transcription factor are independently targeted using
two different promoters. The domains heterodimerize
to become transcriptionally competent and thus drive
transgene expression only at the intersection of the
expression patterns of the two promoters. We use this
system to dissect a neuronal network in Drosophila
by selectively targeting expression of the cell death
gene reaper to subsets of neurons within the network.
Introduction
Understanding how individual neurons, or subsets of
neurons, contribute to the development and function
of neuronal networks requires techniques for selectively
manipulating their function. A growing number of
methods exists for perturbing neuronal function by ex-
pressing transgenes that affect signaling pathways or
cellular viability (reviewed in Miesenbock and Kevreki-
dis, 2005; White et al., 2001; Wulff and Wisden, 2005),
but methods for selectively deploying the expression
of these transgenes to specific subsets of neurons re-
main limited. Binary techniques have proven extremely
useful in expressing foreign transgenes in patterns dic-
tated by the promoters of individual endogenous genes
(for review see Mallo, 2006), but because most genes are
expressed broadly and dynamically, these patterns are
rarely restricted enough to map the functional identities
of cells within specific developmental lineages or neuro-
nal networks.
To provide further restriction of transgene expression,
several ternary techniques have been introduced that
place binary gene activation under the control of a third
*Correspondence: benjaminwhite@mail.nih.govcomponent. In Drosophila, the Gal4-UAS system (re-
viewed in Duffy, 2002), which uses the yeast transcrip-
tion factor Gal4 to activate expression of transgenes
placed downstream of its unique ‘‘upstream activating
sequence,’’ or UAS, has been augmented by the addi-
tion of the Gal4 repressor, Gal80. Targeting of Gal80 ex-
pression to subsets of cells can then be used to restrict
gene expression (Suster et al., 2004), in some cases with
single-cell resolution, as in the widely used MARCM
system (Lee and Luo, 1999). Alternatively, a ‘‘Flp-in’’
technique, which makes UAS-transgene activation con-
tingent on excision of an inserted ‘‘stop cassette’’ by the
Flp-recombinase, has been used to restrict expression
by independently targeting Gal4 and Flp using different
promoters (Stockinger et al., 2005). Similarly in mice,
transgene activation has been made contingent on the
activity of two independently targeted recombinases
by coupling Flp to the Cre-lox system, as in the ‘‘in-
tersectional gene activation’’ technique (Awatramani
et al., 2003; Farago et al., 2006).
To date, ternary systems have been developed
primarily for use in developmental studies to restrict
reporter transgene expression to small numbers of
neurons for lineage analysis and fate mapping. Most
can, in principle, also be used to drive effector transgene
expression to manipulate neuronal function, but usually
with certain limitations. Restriction using the MARCM
technique, for example, is limited to clonally derived
neurons and constrained by the developmental timing
of mitosis in the lineages under study. In recombinase-
based systems, inefficiency of recombination can limit
the extent of gene activation (Ting et al., 2005). Such
systems are also intrinsically irreversible.
To develop an alternative ternary approach for versa-
tile functional manipulation of neuronal activity, we have
taken advantage of the modularity of transcription fac-
tors, which, as first shown for the yeast transcriptional
activator Gal4 (Brent and Ptashne, 1985; Keegan et al.,
1986), often consist of separable functional domains
for site-specific DNA binding (DBD) and transcription
activation (AD). Neither domain can activate transcrip-
tion on its own, but when joined, either covalently or
by noncovalent interactions, the two domains can re-
constitute site-specific gene expression at appropriate
promoter sites. This modularity has been exploited pre-
viously in the construction of chimeric transcription fac-
tors (Gossen and Bujard, 1992; Wang et al., 1994) and in
transcription-based assays for protein interaction do-
mains, such as the widely used yeast two-hybrid system
(Fields and Song, 1989). In the ‘‘Split Gal4’’ system de-
scribed here, we have also exploited this modularity to
design DBD and AD domains, which can be indepen-
dently targeted using different promoters. Each domain
is fused to a heterodimerizing leucine zipper fragment
so that the two domains bind tightly when expressed
together in the same cell to become transcriptionally ac-
tive. By anchoring the expression of one domain to the
expression pattern of one promoter and using other pro-
moters to drive expression of the other domain, tran-
scriptional activity can be reconstituted within restricted
Neuron
426Figure 1. The Ternary Split Gal4 System Im-
proves upon Existing Binary Expression Sys-
tems in Restricting Transgene Expression
(A) Schematic depiction of the Gal4-UAS sys-
tem ofDrosophila, a classic binary system for
targeting transgene expression in vivo. The
first essential component of this system,
shown at left, is a transgene containing the
yeast transcription factor Gal4 downstream
of a promoter/enhancer (P). P drives expres-
sion of Gal4 in flies bearing this transgene in
a cell type-specific manner (shown as a black
region within the CNS). When flies bearing
Gal4 are crossed to flies bearing the second
component of the system, a transgene of in-
terest placed downstream of the Gal4 DNA
recognition site or UAS, this transgene is
also expressed in the same cell type-specific
manner (right).
(B) The Split Gal4 system exploits the fact
that the two functional domains of Gal4, the
DNA-binding (DBD) and transcription-activa-
tion (AD) domains, are separable. In the Split
Gal4 system each domain is fused to a heter-
odimerizing leucine zipper (Zip+ or Zip2) to in-
sure that the two domains associate when expressed in the same cell and reconstitute transcriptional activity. Starting at left, the schematic
shows that the Gal4DBD and AD constructs can be independently targeted using different promoters/enhancers (P1 and P2). When these con-
structs (‘‘hemidrivers’’) are brought together in crosses to flies bearing a UAS-transgene, the transgene is expressed in progeny only at the in-
tersection of the expression patterns of P1 and P2 (designated by the intersection sign, X), where transcriptional activity is reconstituted, as
shown on the bottom right. The Gal4DBD must be used if UAS-transgenes are to be transcribed, but any transcription-activation domain can
be used, as long as it is fused to the leucine zipper fragment complementary to that fused to Gal4DBD.regions of the initial pattern. We introduce two imple-
mentations of this method in which the DBD of the yeast
transcription factor Gal4 is used in conjunction with ei-
ther the Gal4 AD or the activation domain of the more
potent viral transcription factor, VP16. We demonstrate
the utility of the system by functionally dissecting a
simple neural network involved in wing expansion in
Drosophila. We anticipate that the Split Gal4 system
will be broadly applicable to problems in which manipu-
lation of cellular function must be rationally restricted.
Results and Discussion
Development of the Split Gal4 System
To implement the strategy of restricting transgene ex-
pression in vivo by independently targeting transcription
factor domains, we developed tools that could be de-
ployed in the fruit fly, Drosophila melanogaster, in which
the binary Gal4-UAS system for transgene expression is
already well established (Figure 1A, Brand and Perri-
mon, 1993). This system includes several hundred trans-
genic fly lines designed to express reporter and effector
transgenes under the control of the ‘‘upstream activat-
ing sequence’’ recognized by the Gal4 DBD. We there-
fore sought to develop a system (Figure 1B) in which
the Gal4 DBD was paired with an AD potent enough to
drive transgene expression at levels high enough to per-
mit manipulation of cellular function. Previous studies
have indicated that the primary Gal4 AD (i.e., ‘‘region
II,’’ Ma and Ptashne, 1987b) coupled with the Gal4
DBD might promote transcription at levels that are
only a fraction of those produced by intact Gal4 (Ma
and Ptashne, 1987a). We therefore also tested the
more potent AD from the Herpes Simplex Virus 1 tran-
scription factor, VP16.To optimize transcriptional activity, we fused the Gal4
DBD and the ADs to heterodimerizing leucine zippers,
varying the zipper type, site of fusion (N or C terminus),
and length of the polyglycine spacer between the zipper
and the transcription factor domains (see Table S1 in
the Supplemental Data for details). The constructs
that produced maximal transcriptional activity when
cotransfected into Drosophila SL-2 cells are shown
schematically in Figure 2A. These optimal constructs
incorporated synthetic leucine zippers based on the
chicken B-Zip family member Vitellogenin Binding Pro-
tein (Moll et al., 2001). The sequences of these zippers
do not match those ofDrosophila B-Zip family members
(Fassler et al., 2002) and were selected for their strong
heterodimerizing and low homodimerizing potentials.
Transcriptional activities of the optimal constructs, ex-
pressed pairwise in transfected cells and measured in
terms of the relative enzymatic activity of a UAS-b-
galactosidase reporter, were 52% and 84% of that of
intact Gal4 for the Gal4DBD-Gal4AD and the Gal4DBD-
VP16AD pairs, respectively (Figure 2B). The individual
optimized constructs, which we refer to as ‘‘hemi-
drivers,’’ displayed little to no transcriptional activity
when transfected alone.
In Vivo Characterization of the Split Gal4 System
We evaluated the efficacy of the optimized hemidrivers
in vivo in three steps, increasing restriction of transgene
expression at each step. In step 1, we created and
crossed transgenic lines that expressed each hemi-
driver throughout the nervous system. This permitted
evaluation of each hemidriver’s ability to promote neu-
ronal transgene expression when used in concert with
complementary hemidrivers. In addition, it permitted
the assessment of possible side effects of each
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427Figure 2. Optimized Split Gal4 Constructs Efficiently Drive UAS-
Reporter Gene Expression In Vitro and In Vivo in the Drosophila
Nervous System
(A) Schematic representation of the three optimized Split Gal4 con-
structs: (top) the DNA-binding domain of the Gal4 molecule fused at
the N terminus to the Zip2 leucine zipper (see Experimental Proce-
dures), (middle) the major transcription-activation domain of Gal4
fused at the C terminus to the Zip+ leucine zipper (Gal4AD), and
(bottom) a similar AD construct containing the C-terminal acidic do-
main of the VP16 transcription factor. The sawtooth line represents
a flexible linker of ten consecutive glycine residues. NLS, SV40
nuclear localization signal. The Gal4DBD contains an endogenous
N-terminal NLS (not depicted).
(B) Relative transcriptional activities of the Split Gal4 constructs
when expressed in cultured cells, alone and in combination. Tran-
scriptional activity was measured indirectly as the b-galactosidase
activity in lysates of Drosophila SL-2 cells cotransfected with
plasmids containing the indicated Split Gal4 constructs and a
UAS-LacZ gene. b-galactosidase activity was normalized to the total
protein and is expressed as the percentage of the activity measured
in cells transfected with intact Gal4. Bars show average activity in
three transfections.
(C–H) Fluorescence photomicrographs of Drosophila third-instar
larval CNS from animals expressing (C) Gal4DBD alone, (D)
VP16AD alone, (E) Gal4DBD alone, (F) Gal4DBD and Gal4AD, (G) in-
tact Gal4, or (H) Gal4DBD and VP16AD. Expression was driven by
the panneuronal elav promoter. Fluorescence shows expression of
one or two copies of a UAS-EGFP reporter transgene, as indicated.
(E) Long-exposure image (6-fold longer than for the other panels) re-
veals weak expression of the reporter driven by the Gal4DBD con-
struct alone. Here and elsewhere, hemidrivers are denoted by the
promoter used to drive the (superscripted) Split Gal4 construct,
with Gal4DBD abbreviated to DBD, andX denotes the combination
of hemidrivers expressed in a cross.hemidriver’s individual expression. In step 2, we created
lines that expressed each hemidriver in a small set of
identified neurons that expresses Crustacean Cardioac-
tive Peptide (CCAP). Crosses of these lines to comple-
mentary, panneuronal hemidriver lines from step 1 per-
mitted rigorous evaluation of each hemidriver’s ability
to faithfully restrict transgene expression to a set of
neurons. In step 3, we created lines that overlapped in
expression pattern with the lines created in step 2, but
only within distinct subsets of the CCAP-expressing neu-
rons. This permitted validation of the Split Gal4 system
as a tool for mapping the functional identities of defined
subsets of neurons. The results obtained at each step of
evaluation are discussed in the sections below, with the
headings indicating whether the promoters used to
express the hemidrivers (P1 and P2) drive transgene ex-
pression in a common set of neurons (P1 equals P2), in
an included subset (P1 includes P2), or in the intersection
of two distinct sets (P1 overlaps P2).
Step 1: Panneuronal Expression Using the Split Gal4
System (P1 Equals P2)
Transgenic fly lines that expressed each hemidriver
panneuronally were made using the promoter of the
elav gene (Yao and White, 1994) and are referred to as
elavGal4DBD, elavGal4AD, and elavVP16AD. These lines
were viable and healthy, suggesting that expression of
the transcription factor constructs throughout the ner-
vous system is not deleterious in itself. In addition, the
individual hemidrivers appeared transcriptionally inac-
tive in vivo, just as they were in vitro. The progeny of
crosses of each hemidriver line to a line carrying
a UAS-EGFP or UAS-EYFP reporter transgene did not
exhibit obvious nervous system fluorescence at any
stage of development (data not shown). This was true
even for homozygous animals containing two copies
each of the single hemidrivers and the UAS-EGFP trans-
genes (Figures 2C and 2D), although at long exposure
times limited fluorescence was observed in animals ex-
pressing two copies of elavGal4DBD (Figure 2E), suggest-
ing that this hemidriver may have weak transcriptional
activity on its own.
In contrast, pairwise crosses of elavGal4DBD and
elavGal4AD lines in the presence of a UAS-reporter
yielded progeny with bright fluorescence specifically ex-
pressed in the central nervous system (CNS; Figure 2F).
We designate crosses in which DBD and AD hemidriv-
ers are paired, with the intersection symbol, X. All
elavGal4DBDX elavGal4AD crosses, yielded viable progeny
that expressed the reporter transgenes in the nervous
system, in some cases at levels approaching that of in-
tact Gal4 (Figure 2G). Nervous system fluorescence
was strong enough to be observed by epifluorescence
under a dissection microscope as well as by confocal
microscopy from the late embryonic period through
adulthood.
Crosses in which the elavGal4DBD and elavVP16AD hemi-
drivers were paired yielded viable adult progeny with
even stronger nervous system fluorescence (Figure 2H),
though, as noted in Experimental Procedures, many of
these crosses were lethal. Lethality was independent
of reporter gene expression and has not been observed
in any other crosses, including those that drive expres-
sion in all cholinergic neurons, which comprise much
Neuron
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by VP16AD enhancer-trap lines (see below). Overall,
our observations strongly indicate that toxicity is not
a general feature of VP16AD and Gal4DBD coexpression
in neurons and may instead result from disruption of
function in a small number of cells variably represented
in the expression pattern of the elav promoter.
Step 2: The Split Gal4 System Can Faithfully
Target Gene Expression to a Subset of Neurons
(P1 Includes P2)
To confirm the ability of the Split Gal4 system to restrict
transgene expression to a subset of cells within the pat-
tern dictated by a promoter of interest, we first sought to
limit UAS-EGFP expression within the nervous system
to an identified set of neurons. To this end, we generated
a second set of hemidrivers (CCAPGal4DBD, CCAPGal4AD,
and CCAPVP16AD) using the promoter for the CCAP gene,
which has been demonstrated previously (Park et al.,
2003) to be active in approximately 50 neurons of the lar-
val central nervous system (Figures 3A and 3B). We then
performed pairwise crosses, combining complementary
transcription factor domains expressed under the con-
trol of the elav and CCAP promoters, and monitored
the pattern of expression of a UAS-EGFP reporter trans-
gene in the progeny.
The elavGal4DBD X CCAPGal4AD crosses resulted in
UAS-EGFP expression exclusively within the more re-
stricted CCAP pattern (Figure 3C), consistent with the
reconstitution of transcriptional activity in only cells
expressing both transcription factor domains. The re-
ciprocal crosses, namely CCAPGal4DBD X elavGAL4AD,
gave similar results (data not shown), and in both cases
expression within the CCAP-expressing neurons
(NCCAP) was confirmed by double labeling with an anti-
CCAP antibody (Figures S1A–S1C). In most crosses,
some expression was seen in small numbers of non-
CCAP-immunoreactive neurons. This lack of fidelity
was similar in exent to that observed with the CCAP-
Gal4 driver line created by Park et al. (2003), the expres-
sion pattern of which includes non-CCAP-expressing
neurons in some animals (see legend, Figure 3B). With
both Gal4 drivers and Split Gal4 hemidrivers, ‘‘position
effects’’ resulting from the action of genomic enhancers
adjacent to the site(s) of transgene insertion are thus
likely to perturb the transcriptional activity of the
CCAP-promoter.
We determined the frequency of reporter gene ex-
pression in individual CCAP-immunopositive neurons
in multiple preparations using the CCAPGal4AD line with
the greatest fidelity to create a ‘‘consensus expression
pattern’’ as shown in Figure 3D. Comparison of this pat-
tern with the corresponding consensus expression pat-
tern for the CCAP-Gal4 driver line (Figure 3B) reveals
only slight deviations, with the Split Gal4 cross failing
to label two CCAP-expressing neurons in the final
abdominal segment.
Gal4 transcriptional activity is regulated in yeast by
the Gal80 repressor, which binds to a motif included
within the Gal4AD (Ma and Ptashne, 1987a). As shown
in Figure S2, Gal80 also efficiently suppresses reporter
transgene expression in elavGal4DBD X CCAPGal4AD
crosses when coexpressed under control of the CCAP
promoter. The Gal4AD-based implementation of theFigure 3. The Split Gal4 System Restricts UAS-Transgene Expres-
sion to the Intersection of the Expression Patterns of Two Promoters
Comparison of UAS-EGFP expression in the CNS of third-instar lar-
vae driven by (A and B) CCAP-Gal4 or (C–F) combined Split Gal4
hemidrivers made with the panneuronal elav promoter and the pro-
moter for the CCAP gene. (A) UAS-EGFP expression pattern of
CCAP-Gal4 driver. This pattern consists of 48 neurons that express
the neuropeptide CCAP. (B) Consensus expression pattern derived
from analysis of six preparations like the one shown in (A), as
described in Experimental Procedures. (C and D) UAS-EGFP ex-
pression pattern driven by elavGal4DBDXCCAPGal4AD and the corre-
sponding consensus pattern (n = 6). (E and F) UAS-EGFP expression
pattern driven by CCAPGal4DBD XelavVP16AD and the corresponding
consensus pattern (n = 5). Consensus pattern symbols: circles, the
canonical CCAP-expressing neurons, showing their anatomical po-
sitions in the CNS (Br, brain; SEG, subesophageal ganglion; T1–3,
the three thoracic ganglia; A1–A8, the eight abdominal ganglia);
green circles, neurons that expressed EGFP in greater than two-
thirds of the preparations; gray circles (see A8 in [D] and [F]), neurons
that expressed EGFP in less than two-thirds of preparations. Solid
green circles, high EGFP expression; open green circles, low
EGFP expression. A few ‘‘ectopically’’ labeled CCAP-immunonega-
tive cells were observed for each driver or hemidriver combination.
Their average number per preparation (6SD) was 3 6 2 (B), 4 6 2
(D), and 2 6 2 (F).
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429Figure 4. Genetic Ablation of NCCAP Neurons
Using the Split Gal4 System Causes Pupal
Lethality and Wing-Expansion Deficits that
Correlate with Expression Strength
(A) Cumulative percentage of progeny dis-
playing the pupal lethal (black bars) and un-
expanded wing (gray bars) phenotypes, fol-
lowing ablation of neurons within the CCAP
expression pattern by targeted expression
of one or two copies of the cell death gene
reaper using the indicated driver or combina-
tion of hemidrivers. If these phenotypes were
not present, no bar is shown. *, embryonic or
early larval lethality. (Inset) Adult wing pheno-
types. (Left) Unexpanded wings of a newly
emerged adult fly. (Right) Same fly after
expanding its wings. Adult flies lacking the
CCAP-expressing neurons permanently re-
tain the unexpanded wing phenotype.
(B–E) Confocal micrographs of CCAP-immu-
noreactive neurons in the nervous systems
of pharate adult flies expressing UAS-reaper
driven by the indicated drivers or hemidriver
combinations. (B) CCAP-Gal4, (C) elavGal4DBD
and CCAPGal4AD, (D) CCAPGal4DBD and
elavVP16AD, and (E) CCAPGal4DBD alone. The
CCAP-immunopositive neurons shown sur-
vived the developmental expression of
reaper. The average number of surviving
NCCAP neurons (6SD) in preparations like
those shown in panels (B)–(E) were 6.6 6 0.9
(n = 5), 15.3 6 1.5 (n = 9), 0 6 0 (n = 4), and 47.6 6 0.5 (n = 5), respectively. Abbreviations as in Figure 3, except AG, fused abdominal ganglion
of the pharate adult CNS. On average, the pharate adult AG has two fewer NCCAP neurons than are found in the larval abdominal ganglia. Also, the
identity of NCCAP neurons in the pharate adult brain is unlikely to correspond to those found in the larval brain.Split Gal4 system can thus be used in conjunction with
the increasing number of transgenic Gal80-expressing
fly lines, further extending the range of application of
the technique. In particular, coupling the Split Gal4 tech-
nique to the TARGET system (McGuire et al., 2003),
which exploits a temperature-sensitive Gal80 mutant
to temporally regulate Gal4 activity, should permit con-
ditional, as well as spatially restricted, expression of
genes of interest.
Restricted expression of the UAS-EGFP reporter
within NCCAP was also achieved with the VP16AD con-
struct. The most faithful expression pattern was
observed in CCAPGal4DBD X elavVP16AD crosses, when
expression of the Gal4DBD domain was anchored to
NCCAP (Figure 3E and Figures S1D–S1F). Interestingly,
the reciprocal crosses (elavGal4DBD X CCAPVP16AD) re-
sulted in expansion of the expression pattern to include
numerous neurons outside of NCCAP with all CCAP
VP16AD
lines tested (Figures S1G–S1I). This infidelity of expres-
sion presumably derives from ectopic VP16AD expres-
sion and may be the result of a cryptic enhancer in the
CCAPVP16AD construct. In any case, it does not affect ap-
plications in which precise targeting of the VP16AD
hemidriver is unnecessary, such as those using en-
hancer-trap lines discussed in step 3. However, the pos-
sibility of imprecise targeting of this hemidriver must be
considered if defined expression of VP16AD is desired.
To further investigate the selectivity of transgene ex-
pression driven by Split Gal4 hemidrivers and to confirm
the utility of the Split Gal4 system in manipulations of
neuronal function, we targeted expression of the cell
death gene reaper to NCCAP in elav
Gal4DBDXCCAPGal4AD
and CCAPGal4DBD X elavVP16AD crosses. As shown inFigure 4A, expression of UAS-reaper under the control
of the elav-Gal4 driver results in early developmental le-
thality with almost all animials dying at the embryonic or
early larval stages. In contrast, reaper expression under
control of the CCAP-Gal4 driver results in the two devel-
opmental phenotypes first described by Park et al.
(2003): animals either die as pupae with morphological
defects characteristic of head eversion failure, or survive
to adulthood without expanding their wings (UW; Fig-
ure 4A). Immunohistochemical examination of animals
from such crosses shows that reaper expression by
CCAP-Gal4 typically kills most, but not all, of the
CCAP-expressing neurons during development (Fig-
ure 4B), whereas control crosses show no neuronal
mortality (Figure 4E).
As expected, expression of UAS-reaper using the
Split Gal4 system led to pupal lethality and wing expan-
sion deficits at levels that correlated with the extent of
NCCAP ablation. In addition, the results better define
the different efficacies of the two implementations of
the Split Gal4 system. Expression of a single copy of
the reaper transgene in NCCAP using the Split Gal4 sys-
tem with Gal4AD (elavGal4DBD X CCAPGal4AD) was with-
out effect, but expression of two copies caused wing
expansion deficits in 90% of progeny, with little con-
comitant pupal lethality (Figure 4A). On average, expres-
sion of two copies of UAS-reaper resulted in the death of
approximately two-thirds of the NCCAP neurons (Fig-
ure 4C). The Split Gal4 system, implemented with
Gal4AD, thus clearly drives reaper expression less po-
tently than intact Gal4, and the absence of the pupal le-
thal phenotype indicates that the neurons responsible
for it were not killed or were killed in insufficient numbers
Neuron
430Figure 5. A Subset of NCCAP Neurons Is
Cholinergic and Lies within the Expression
Pattern of the Choline Acetyltransferase
Promoter
(A) Consensus labeling pattern showing the
overlap of Cha-Gal4 expression (detected
with UAS-EGFP) with NCCAP (detected by
anti-CCAP immunolabeling; n = 9). Circles,
CCAP-immunopositive neurons. Green cir-
cles, EGFP labeled in greater than one-third
of the preparations. Light-blue circles, EGFP
labeled in one-third or less of the prepara-
tions. Gray circles, neurons that were never
EGFP labeled. Filled circles, consistently
high EGFP expression (see Experimental
Procedures). Open circles, low EGFP expres-
sion. In paired NCCAP neurons in hemi-
segments T3–A4, one was typically strongly
CCAP immunopositive and the other was
more weakly labeled. For convenience, we have shown the strongly expressing neuron as medial to the weakly expressing one. This does
not necessarily represent their anatomical positions. (B–J) High-resolution confocal micrographs showing anti-CCAP immunoreactivity (B, E,
and H), EGFP expression (C, F, and I), and their overlap (D, G, and J). For each set of images, individual neurons are indicated by arrows and
dotted outlines. Boxes in (A) show the anatomical location of the corresponding images. In hemisegments T3 and A1–A4, only the more weakly
CCAP-immunoreactive neuron of the pair expresses EGFP.even by two copies of the UAS-reaper transgene. In con-
trast, expression of a single copy of the reaper trans-
gene in CCAPGal4DBD X elavVP16AD crosses resulted in
nearly complete pupal lethality (Figure 4A) and the death
of almost all NCCAP neurons (Figure 4D), indicating that
this implementation of the Split Gal4 system drives
reaper expression more potently than intact Gal4. These
results are consistent with the levels of EGFP reporter
gene expression seen using the two implementations
of the system (see Figures 2F–2H). Control crosses ex-
pressing single hemidrivers and one or two copies of
the reaper transgene produced progeny without pupal
mortality or significant wing expansion deficits (Fig-
ure 4A). Overall, our results indicate that the Split Gal4
system drives reaper expression in NCCAP at levels suf-
ficient to ablate some or all of these neurons, with
VP16AD providing considerably more potent transgene
expression than Gal4AD.
Step 3: The Split Gal4 System Can Target Gene
Expression to the Intersection of Two Overlapping
Expression Patterns (P1 Overlaps P2)
The greatest utility of the Split Gal4 system lies in its po-
tential to limit transgene expression to the intersection
of two distinct but overlapping expression patterns.
We describe here an example of this application using
two defined promoters. The next section describes
a second example using hemidrivers made with unde-
fined promoters (i.e., enhancer-trap lines) to drive gene
expression at the intersection of two patterns.
The Gal4AD, with its high degree of fidelity when ex-
pressed under a specific promoter, is particularly useful
when both the AD and Gal4DBD hemidrivers must be
faithfully targeted. We used the CCAPGal4AD in conjunc-
tion with a Gal4DBD hemidriver made with the choline
acetyltransferase (Cha) promoter (Salvaterra and Kita-
moto, 2001) to selectively drive transgene expression
in cholinergic NCCAP neurons. Preliminary immunohisto-
chemical studies indicated that at least some NCCAP
neurons were cholinergic, and to provide a baseline for
assessing the fidelity of ChaGal4DBD X CCAPGal4AD-driven expression, we determined the consensus pat-
tern of Cha promoter activity within NCCAP immunohisto-
chemically (Figure 5A). As indicated in Figure 5, certain
CCAP-immunopositive neurons, such as the bilaterally
represented pairs in the brain (Figures 5A and 5B–5D),
are consistently double labeled in Cha-Gal4 > UAS-
EGFP preparations. In the ventral nerve cord, the
more-weakly immunopositive member of the pair of
CCAP-expressing neurons in hemisegments A1–A4 is
also often EGFP labeled, as shown in the examples of
Figures 5E–5J, while the strongly immunopositive mem-
ber of this pair is never EGFP labeled. In general, we ob-
served considerable variability in the pattern of overlap,
suggesting extensive variability of the Cha-Gal4 expres-
sion within NCCAP, but the consensus labeling pattern
(Figure 5A), derived from nine double-labeled prepara-
tions, shows that 18 of the 48 NCCAP neurons are found
within the Cha-Gal4 pattern in greater than a third of
the preparations, while 13 other neurons are found dou-
ble labeled at lower frequency.
Figure 6 shows the corresponding results obtained
with the Split Gal4 system, in which UAS-EGFP expres-
sion was driven by ChaGal4DBD X CCAPGal4AD (Figures
6A–6C). Whole mounts of the CNS from these animals
were stained with anti-CCAP antibody (Figure 6D) to
positively identify each EGFP-labeled neuron, and a con-
sensus expression pattern was determined from the ex-
amination of multiple animals (Figure 6I). As with the
Cha-Gal4 driver, and therefore unsurprisingly, there
was considerable variability in the expression pattern,
but in all preparations almost all EGFP-expressing neu-
rons were also CCAP immunopositive (Figure 6D), and
there was good correspondence in the two consensus
expression patterns (compare Figure 6I with Figure 5A).
In particular, the neurons most frequently observed in
the Split Gal4 pattern were the CCAP-immunopositive
neurons of the brain (Figure 6D, arrowheads) and
specific hemisegmentally represented neurons in the
ventral nerve cord (Figure 6D, box). Just as observed
with the Cha-Gal4 driver, the latter neurons in
hemisegments A1–A4 corresponded to the weakly
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431Figure 6. Targeting the Cholinergic Subset of
NCCAP, Using Complementary Hemidrivers
Made with the Cha and CCAP Promoters
The pattern of UAS-EGFP expression in the
CNS of Drosophila third-instar larvae driven
by the Split Gal4 hemidrivers ChaGal4DBD
and CCAPGal4AD. (A and B) Expression pat-
terns of the promoters used to make the
ChaGal4DBD and CCAPGal4AD hemidriver
lines. (A) Cha-Gal4 > UAS-EGFP (blue pseu-
docolor). (B) CCAP-Gal4 > UAS-EGFP (red
pseudocolor). (C and D) Restricted pattern
of UAS-EGFP expression within NCCAP in
ChaGal4DBD X CCAPGal4AD crosses. (C) A
representative example of EGFP expres-
sion. (D) Both EGFP expression (green)
and CCAP immunostaining (magenta) in
sample from (C). Anatomical abbreviations
are as in Figure 3. Consistently double-
labeled neurons in the brain (arrowheads)
and in hemisegments A1–A4 (box in [D])
are indicated. (E) UAS-EGFP driven by
CCAP-Gal4 expresses in both strong and
weak CCAP-immunoreactive cells of hemi-
segments A1–A4. (F–H) Higher-magnifica-
tion images of the boxed region in (D)
showing restriction of EGFP expression to
only the more weakly immunoreactive
NCCAP neuron of the pair in hemisegments
A1–A4. (F) UAS-EGFP expression. (G)
CCAP immunolabeling. (H) Merged image
of (F) and (G). (I) Consensus pattern of
UAS-EGFP expression driven by ChaGal4DBD
X CCAPGal4AD, derived from seven prepara-
tions. The average frequency and intensity
of labeling for each identified neuron are
designated as in Figure 5. Boxed region,
hemisegments A1–A4 shown in (F)–(H). Ectopically labeled neurons are not represented in the consensus pattern. On average, 7 6 2
(n = 7) non-CCAP-immunoreactive cells were observed per preparation. Some of these, such as the two in the brain, appear to correspond
to cells also sometimes seen in CCAP-Gal4 labeling patterns.CCAP-immunopositive neuron of a pair (Figures 6F–6I,
box), both of which are equally well labeled by CCAP-
Gal4 (Figure 6E).
Restriction of Gene Expression to Arbitrary Subsets
of Cells within a Group of Interest Using VP16AD
Enhancer-Trap Hemidrivers
Another strategy for restricting expression within a pat-
tern of interest, particularly useful when there are no
known promoters with overlapping expression patterns,
uses enhancer-trap lines (Bellen et al., 1989) to express
the complementary hemidriver. Enhancer-trap con-
structs are made with a minimal promoter and express
in ‘‘arbitrary’’ patterns dictated by local enhancer ele-
ments near the site of transgene integration into the
genome. Because the fidelity of expression of the
enhancer-trap construct is immaterial, the VP16AD,
with its potential for driving transgene expression at
high levels, is useful for this application. We therefore
made enhancer-trap lines with the VP16AD construct
(ETVP16AD) and selected those with expression patterns
that overlapped with NCCAP. The broad expression pat-
terns of two such lines (ETVP16AD-N4 and ETVP16AD-N6),
revealed by crosses to elavGal4DBD, are shown in Figures
7A and 7C, respectively. The restricted patterns of ex-
pression within NCCAP (Figure 7B), generated by crosses
of these lines to CCAPGal4DBD, are shown in Figures 7D
and 7F, respectively. As is evident from their consensusexpression patterns (Figures 7E and 7G), the two en-
hancer-trap hemidrivers limit expression to two nearly
mutually exclusive subsets of NCCAP. ET
VP16AD-N4
crosses to CCAPGal4DBD drive expression almost exclu-
sively in neurons of the subesophageal and thoracic
ganglia, while those of ETVP16AD-N6 drive expression
primarily in the brain and abdominal ganglia.
Dissection of Neural Network Function
Using the Split Gal4 System
Having identified enhancer-trap lines capable of selec-
tively expressing transgenes in discrete subsets of
NCCAP, we next used them to probe the functional iden-
tities of the neurons within this group. As indicated
above, NCCAP plays a critical role in wing expansion in
the early adult, and we wished to determine which neu-
rons within this group might be necessary and/or suffi-
cient for this process. We therefore ablated the subsets
of NCCAP neurons included in the ET
VP16AD-N4 and
ETVP16AD-N6 expression patterns using UAS-reaper
and correlated the patterns of the surviving NCCAP neu-
rons with the wing-expansion phenotype.
We used anti-CCAP immunostaining of the nervous
system to assess the patterns of surviving NCCAP neu-
rons (Figures 8A and 8E). Because the CCAP-expressing
neurons apoptose shortly after eclosion (Draizen et al.,
1999), it was necessary to evaluate the patterns of the
surviving NCCAP neurons in pharate adults, that is, at
Neuron
432Figure 7. Split Gal4 Enhancer-Trap Lines Can
Be Used to Target Distinct Subsets of Neu-
rons within NCCAP
Patterns of EGFP expression in the CNS of
Drosophila third-instar larvae driven by the
CCAPGal4DBD hemidriver combined with two
different VP16AD enhancer trap lines. (A–C)
Expression patterns of two VP16AD en-
hancer-trap hemidrivers and CCAP-Gal4.
Nervous system expression (blue pseudo-
color) of (A) the ETVP16AD-N4 and (C)
ETVP16AD-N6 enhancer-trap lines revealed by
combining them with the elavGal4DBD hemi-
driver in the presence of a UAS-EGFP
reporter. (B) CCAP-Gal4 > UAS-EGFP. (D–G)
Restricted patterns of UAS-EGFP expression
generated by (D) CCAPGal4DBD X ETVP16AD-
N4, and (F) CCAPGal4DBD X ETVP16AD-N6,
and (E and G) their corresponding consensus
patterns. Consensus patterns were derived
from four ETVP16AD-N4 and six ETVP16AD-N6
double-labeled preparations, respectively,
with neurons represented as in Figure 5.a stage just before eclosion and wing expansion. There-
fore, we could not compare wing expansion with the sur-
viving NCCAP neurons in individual animals. To help iden-
tify these neurons, which differ somewhat in number and
position from those of the larval stage, we double la-
beled the preparations with an antibody to the hormone
bursicon (Figures 8B–8C, 8F, and 8G), which is ex-
pressed in a subset of NCCAP, including 14 neurons in
the abdominal ganglion (Figure 8I). Ablations performed
using the ETVP16AD-N4 hemidriver primarily affected
neurons of the subesophageal and thoracic ganglia
(Figure 8D, black circles), as expected from the expres-
sion pattern in third-instar larvae (Figure 7E). Six abdom-
inal ganglion neurons that appear in the expression pat-
tern only during pupal development (data not shown),
and which do not express bursicon, were also ablated.
In contrast, ablations performed using the ETVP16AD-N6
hemidriver mostly spared the neurons of the thoracic
and subesophageal ganglia, but eliminated, on average,
12 of the 30 abdominal ganglion neurons, including nine
that express bursicon (Figure 8H). Interestingly, only ab-
lations performed with the ETVP16AD-N4 hemidriver
yielded animals that failed to expand their wings (Fig-
ure 8J). This effect was not fully penetrant, but because
there were slight variations in the patterns of cell death
from animal to animal (see Figure 8C, legend), it is likely
that the 15% of animals that expanded their wings
normally corresponded to those in which some small
number of critical neurons were not killed.
The two lines therefore identify functionally, as well as
anatomically, distinct subsets of NCCAP. The set of neu-
rons surviving the ablation with ETVP16AD-N6 (Figure 8H,red) is clearly sufficient to support wing expansion, and
the set surviving ablation with ETVP16AD-N4 (Figure 8D,
red) is insufficient for wing expansion. Conversely,
some or all of the neurons ablated in crosses using
ETVP16AD-N4 (Figure 8D, black circles) must be neces-
sary for wing expansion. If we remove from this latter
group the small number of neurons that are clearly un-
necessary, because they are ablated without effect in
ETVP16AD-N6 crosses (e.g., the middle pair of subeso-
phageal neurons), we are left with a minimal subset of
neurons, some or all of which must be necessary for
wing expansion (Figure 8K, red).
This ‘‘critical subset’’ represents part of a larger group
of previously identified neurons, and our results with the
Split Gal4 system confirm and extend an earlier model of
NCCAP function. Previously, we showed that neurons
within NCCAP act as a small network with output and reg-
ulatory functions, both of which are necessary for wing
expansion (Luan et al., 2006). The critical subset identi-
fied here (Figures 8K–8L, red filled) definitively impli-
cates several neurons within the broad group previously
identified as candidate regulatory neurons as required
for wing expansion (Figure 8L, blue circles). However,
as can be seen in Figure 8L, the critical subset cannot
be sufficient for wing expansion, since it does not in-
clude any of the 14 bursicon-expressing neurons that
comprise the output group (green circles). As shown in
Figure 8H, ablation of up to nine of the bursicon-ex-
pressing neurons with ETVP16AD-N6 does not compro-
mise wing expansion, suggesting that some or all of
the remaining five bursicon-expressing neurons are
necessary. Alternatively, it is possible that the output
Combinatorial Restriction of Transgene Expression
433Figure 8. Genetic Ablation of Neurons within
NCCAP Using the Split Gal4 System Identifies
Anatomically and Functionally Distinct Sub-
sets of This Network
(A–D) Pattern of NCCAP neuronal survival
after ablation by UAS-reaper, driven by
CCAPGal4DBD X ETVP16AD-N4. (A) Confocal
image showing surviving CCAP-immunopos-
itive cells in the CNS of a pharate adult. (B)
Pattern of bursicon immunoreactivity in
the same double-labeled preparation. (C)
Merged image of (A) and (B). The average
number of surviving NCCAP neurons (6SD)
from seven preparations was 30.3 6 2.1. (D)
Consensus pattern of surviving (red filled cir-
cles) and ablated (black open circles) NCCAP
neurons. Note that ETVP16AD-N4 expression
within NCCAP changes developmentally so
that more neurons are killed than are seen in
the larval CNS expression pattern (Figure 7E).
ET-N4, enhancer-trap line ETVP16AD-N4.
(E–H) NCCAP neuronal survival after ablation
by UAS-reaper, driven by CCAPGal4DBD X
ETVP16AD-N6, similar to (A)–(D). The average
number of surviving NCCAP neurons (6SD)
from eight preparations was 32.9 6 5.6.
ET-N6, enhancer-trap line ETVP16AD-N6.
(I) The patterns of anti-CCAP (magenta) and
anti-bursicon (green) labeling in the CNS of
a control animal are shown for comparison.
The pharate adult CNS typically has 48 NCCAP neurons, including 14 bursicon-immunopositive neurons in the AG and one or two pairs in the SEG.
(J) Percentage of progeny with unexpanded wings in crosses with UAS-reaper driven by CCAPGal4DBD X ETVP16AD-N4 and CCAPGal4DBD X
ETVP16AD-N6. Gray bar shows the frequency of the unexpanded wing phenotype. No bar denotes normally expanded wings.
(K) A critical subset (red filled black circles) of neurons within NCCAP, some or all of which must be necessary for wing expansion. This subset
includes all neurons ablated in crosses with ETVP16AD-N4 that were not also ablated in crosses with ETVP16AD-N6. Neurons ablated with
ETVP16AD-N6 are clearly not necessary for wing expansion since flies from crosses with this hemidriver showed normal wing expansion. The crit-
ical set does not contain any of the bursicon-expressing neurons in the AG. Because the identities of the non-bursicon-expressing neurons in the
abdominal ganglion are difficult to determine, it is unclear whether the subset of AG neurons ablated using ETVP16AD-N4 overlaps with the subset
ablated using ETVP16AD-N6. We have therefore included all ablated abdominal ganglion neurons from (D) in the critical set.
(L) Schematic of NCCAP comparing the critical set of NCCAP neurons (red fill) defined in (K), with previously identified candidate output (green open
circles) and regulatory (blue open circles) neurons within the NCCAP network (Luan et al., 2006). The critical set identifies a subset of the previous,
broadly defined regulatory group as important for wing expansion.function is distributed and that various subsets of the
output group are sufficient to promote wing expansion.
Although further work with other enhancer-trap lines
and other effectors will be required to elucidate the indi-
vidual functional identities of neurons within NCCAP, this
example illustrates how the Split Gal4 system can be
used to systematically subdivide and define the func-
tional elements of a neuronal circuit.
Conclusions
The Split Gal4 technique introduced here is a general
and versatile method for targeting transgene expression
to subsets of neurons within a pattern of interest.
Because it uses the Gal4DBD, it is compatible with the
hundreds of UAS-effector lines already available in
Drosophila. Its implementation using the Gal4AD also
makes it compatible with the growing number of Gal80
lines and permits an additional level of spatial or tempo-
ral control. The two implementations of the technique
presented have complementary strengths. The Gal4AD,
although weaker than the VP16AD, can drive effector
transgene expression at levels sufficient to manipulate
neuronal viability and function and can be targeted
with high fidelity when used with specific promoters.
The VP16AD, as we have shown, is better suited for
use in enhancer-trap constructs where its lower pro-
moter fidelity is unproblematic and its higher transcrip-tional activity permits even weak effector transgenes
to be used at single-copy dosages. Although expression
of the VP16AD together with the GalDBD may be toxic in
a small population of neurons, as evidenced by the gen-
eral lethality of panneuronal expression, such toxicity is
clearly not the rule, as we have not observed it in any
other application, including applications using VP16AD
enhancer trap lines with broad expression in the nervous
system (Figures 7A and 7C).
We have demonstrated the utility of the Split Gal4
technique in the field of neuronal circuit analysis, where
we expect it will find fertile application. It should be pos-
sible to use the technique not only to subdivide known
neuronal groups but also to perform screens analogous
to current Gal4 enhancer-trap screens to identify as yet
unknown neuronal substrates of physiological pro-
cesses or behaviors. Unlike current screens, however,
it should be possible to use the Split Gal4 technique
iteratively, to successively refine the identification of
neuronal substrates within a group of interest once it is
identified, as outlined in Figure S3. The level of resolu-
tion attainable with the Split Gal4 system may vary
depending on the homogeneity of gene expression in
the cell group of interest, but given the high degree of
neuronal specialization normally observed, this is un-
likely to be a major limitation. We also anticipate that
the usefulness of the Split Gal4 system introduced
Neuron
434here will extend beyond the nervous system to other tis-
sues and other fields of research. Finally, while we have
implemented the Split Gal4 technique in Drosophila,
there is no reason it cannot be implemented in other
genetic model organisms, such as zebrafish or mice,
where similar transcriptional systems for the expression
of foreign genes exist.
Experimental Procedures
Generation of Optimized Hemidriver Constructs
The optimized Gal4DBD, Gal4AD, and VP16AD constructs used for
in vitro testing were assembled between the EcoRV and HpaI restric-
tion sites (Figure S4A) in the pActPL vector (Wei et al., 2000) using
PCR fragments corresponding to the transcription factor, polygly-
cine linker, and the heterodimerizing leucine zipper domains. Tran-
scription factor PCR templates were made to pGBKT7 (Clontech),
pGADT7 (Clontech), and pUHD15-1 (Resnitzky et al., 1994) and
were designed to amplify sequences encoding amino acids 1–147
(Gal4DBD) and 768–881 (Gal4AD) of Gal4, and 413–490 (VP16AD)
of VP16, respectively. The heterodimerizing leucine zipper domains
corresponded to the RR12EE345L (Zip
2) and EE12RR345L (Zip
+) se-
quences described by Moll et al. (2001) and were generated from
synthetic oligonucleotides with codon usage optimized for Dro-
sophila expression. A point mutation inadvertently introduced by
PCR resulted in a Y/N mutation at amino acid 36 in the EE12RR345L
domain used in the Gal4AD and VP16AD constructs. The transcrip-
tion factor sequences of all pActPL constructs are flanked by unique
restriction sites at the 50 (NotI) and 30 (AscI) ends.
Generation of Transformation Vectors and Transgenic Fly Lines
The elavGal4DBD, elavGal4AD, and elavVP16AD transformation con-
structs used to make transgenic flies were made from the pCaST
vector as described in Figure S4B. This vector was derived from
pP{elav-GeneSwitch} (Osterwalder et al., 2001) by replacing an
EcoRI-XbaI fragment containing the elav-promoter and GeneSwitch
sequences with a polylinker containing EcoRI-BglII-NotI-AscI-XbaI
restriction sites to make pCaST. The ChaGal4DBD, CCAPGal4DBD,
CCAPGal4AD, and CCAPVP16AD transformation constructs were gen-
erated from a derivative of pCaST, called X11 (Figure S4C), which
was made by replacing the EcoRI-elav-NotI fragment of pCaST-
elavGal4DBD with a polylinker containing EcoRI-AvrII-BglII-PmeI-
NotI sites. The enhancer trap constructs ETGal4AD and ETVP16AD
were made by inserting NotI-Gal4AD-AscI and NotI-VP16AD-AscI
fragments into pEG117 (Giniger et al., 1993), after replacing the
KpnI site in the polylinker of this vector by AscI (Figure S4D).
Generation and Characterization of Transgenic Fly Lines
P element injections and isolation of transformants were performed
for all plasmids by Genetic Services, Inc. Six to fourteen indepen-
dent lines were made for each construct, and the chromosomal lo-
cations of the transgenes were determined by segregation analysis.
In step 1, a UAS-EYFP or UAS-EGFP transgene was introduced into
the elavGal4DBD lines, and these lines were crossed pairwise with
elavGal4AD and elavVP16AD lines to determine viability and fluores-
cence expression levels of the progeny. Of the ten elavGal4DBD lines
we made, only one (elavGal4DBD-H9) yielded viable adult progeny in
pairwise crosses to elavVP16AD hemidrivers. Crosses made with the
other nine lines died as embryos or early larvae. Neither the pattern
nor levels of fluorescence in these embryos differed overtly from
those observed in embryos from viable crosses, and in all cases
the fluorescence intensity was very high. The mortality is unlikely
to be due either to toxicity of the highly expressed reporter, since
identical crosses lacking a UAS-transgene also failed to yield viable
progeny, or to transcriptional squelching (Cahill et al., 1994), since
animals expressing only the elavVP16AD construct are viable and
healthy.
Transgenic lines generated in steps 2 and 3 were characterized
similarly to those generated in step 1. Consensus expression pat-
terns were derived for at least two independent CCAPGal4DBD,
CCAPGal4AD, and CCAPVP16AD lines by multiple pairwise crosses to
complementary panneuronal hemidrivers. Independent lines ex-
pressing the same construct had similar consensus patterns in allcases. In step 3, consensus patterns were determined for three inde-
pendent ChaGal4DBD lines in pairwise crosses to two independent
CCAPGal4AD lines.
Other Fly Stocks
The Gal4 driver and UAS-reporter/effector lines used in this study:
yw; +; CCAP-Gal4 (Park et al., 2003); yw; UAS-2XEGFP; UAS-
2XEGFP (Halfon et al., 2002), and yw; +; elav-Gal4 (Luo et al.,
1994); w; Cha-Gal4-19B; + (Salvaterra and Kitamoto, 2001). The w;
rpr; + and Canton-S lines were from the Bloomington Stock Center.
yw; CCAP-Gal80; Dr/TM3,Sb (ET1-B1A) is a second chromosome in-
sert of the construct described in Luan et al. (2006). All flies were
raised on standard corn meal-molasses medium and maintained
at 25C/65% relative humidity on a constant 12 hr light/dark cycle.
Cell Culture, Transfection, and b-Galactosidase
Activity Measurement
Drosophila SL2 cells were cultured and transfected according to
previously described methods (Wei et al., 2000). For each measure-
ment, 23 106 cells were transfected 24 hr after plating using Fugene
6 (Roche Diagnostics) and 2 mg of plasmid(s). Plasmids included
pActPL vectors containing the intact Gal4, Gal4DBD, Gal4AD,
and/or VP16AD transcription factor constructs, together with a
UAS-nucLacZ reporter plasmid. The pRmHa30 vector was used as
a carrier when necessary to insure addition of the same amount
of DNA in all transfections. Seventy-two hours after transfection,
cells were lysed and b-galactosidase activity was quantified using
the b-gal Reporter Gene Assay, Chemiluminescent Kit (Roche
Diagnostics).
Immunohistochemistry and Microscopy
Wandering third-instar larvae or late-stage, black-winged pharate
adults were dissected in PBS, and the excised nervous systems
were fixed, permeabilized, and stained as described previously
(Luan et al., 2006). Antibody labeling was carried out with rabbit
anti-CCAP (Ewer and Truman, 1996) at 1:5000 dilution, and mouse
anti-bursicon b-subunit (Luo et al., 2005) at 1:250 dilution. Alexa
Fluor 488-coupled goat-anti-rabbit and Alexa Fluor 596-coupled
goat-anti-mouse fluorescent secondary antibodies were from Invi-
trogen. Whole-mount preparations were imaged with a Nikon C-1
confocal microscope. Optical sections were acquired using a 203
objective or 403 objective for all figures except the high-resolution
images of anti-CCAP immunostaining shown in Figures 5B–5J and
6E–6H, which were acquired using a 603 oil-immersion objective.
All images of the brain and ventral nerve cord are volume-rendered
Z stacks.
Analysis of Expression Patterns and Immunoreactivity
UAS-EGFP expression driven by intact Gal4 or by Split Gal4 hemi-
drivers varied somewhat between individuals. To represent the fre-
quency and intensity of UAS-EGFP expression in individual identi-
fied NCCAP neurons, we created consensus expression patterns
derived from multiple CNS preparations of each genotype. Each im-
age from the confocal Z stack containing a CCAP-immunopositive
neuronal soma was then evaluated for overlapping UAS-EGFP ex-
pression. The intensity (I) of labeling of each soma was scored on
a scale of 0–3. The consensus intensity value for each identified
CCAP-expressing neuron was calculated by averaging all values
for this neuron across preparations. In the consensus patterns for
third-instar larvae, cells with average values of IR 2 are represented
as filled circles. Open circles have average values of 0 < I < 2. The
frequency with which each neuron expressed EGFP was equal to
the number of preparations in which I s 0 for that neuron divided
by the total number of preparations, and is represented as described
in the figure legends.
For experiments in which reaper was used to ablate CCAP-ex-
pressing neurons, the number and identity of the surviving cells
were determined by examining anti-CCAP and/or anti-bursicon-la-
beled preparations imaged by confocal microscopy. Surviving neu-
rons in each preparation were counted and the means and standard
deviations calculated for all preparations within an experiment. In
the consensus patterns of Figure 8, a cell is represented as ‘‘ab-
lated’’ if it was present in less than one-third of the samples.
Combinatorial Restriction of Transgene Expression
435Analysis of Lethality and Wing Expansion Phenotypes
The UAS-reaper transgene used for genetic ablation in this paper is
less potent than the one used previously by Park et al. (2003) and
was selected to better distinguish the relative efficacies of the
Gal4AD and VP16AD hemidrivers. In ablation experiments, wing
phenotypes were scored as described in Luan et al. (2006), at least
24 hr after eclosion to ensure that the final phenotype had been at-
tained. Pupal mortality was assessed 7 days after a cross had
been terminated and all live animals had eclosed, by dividing the
number of dead pupae by the total number of live progeny plus
dead pupae generated by the cross.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/3/425/DC1/.
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